Tovorafenib is a Pan-Raf Inhibitor for Gliomas Research
BRAFV600E is the most frequent mutation in BRAF (serine/threonine-protein kinase B-raf). It is a proto-oncogene and the most commonly mutated kinase in human cancers. BRAFV600E can be detected in glioma,…